Software stock Dropbox Inc (NASDAQ:DBX), which was one of our successful top picks in 2024, is down 4.2% in the last three days, pulling back to support at the $28 level. However, a certain trendline popping up on the charts could signal a short-term bounce. 

Per Schaeffer's Senior Quantitative Analyst Rocky White, DBX has pulled back to its 50-day moving average. More specifically, the security is within 0.75 of the trendline's 20-day average true range (ATR) after spending at least 80% of the last 10 days and 80% of the last two months above it.

Within these parameters, six other signals occurred in the past three years. DBX was higher one month later 83% of the time after these events, averaging a 4.9% gain. From their current perch at $28.30, a similar move would put the shares right under the $30 level, erasing its losses from the past few days.

Dropbox stock has been popular amongst put traders lately, and an unwinding of this pessimism could provide further tailwinds. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), DBX's 10-day put/call volume ratio of 3.28 and 50-day put/call volume ratio of 1.90 both rank higher than 97% of readings from the past year. 

Echoing this sentiment is the equity's Schaeffer's put/call open interest ratio (SOIR) of 1.95, which sits in the 84th percentile of annual readings. This suggests there's been an unusual appetite for bearish bets of late.

Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion. The merger is still awaiting review from the German Economy Ministry.

Today's pop has CVAC trading at 52-week highs, conquering resistance at the $5 level, which kept it in penny stock territory for the last year. Since the start of 2025, the equity is up 63.5%. 

CureVac stock's typically quiet options pits are booming today. The stock has already seen 45 times the average daily options volume, with the most activity at the June 6 call, where new positions are being opened.

Short interest has been unwinding, down 14.1% in the last two weeks, but the amount sold short still accounts for 4.4% of the stock's available float. It would take shorts over six days to cover, at CVAC's average pace of trading. 

Software firm Datadog Inc (NASDAQ:DDOG) is trading 2.8% higher at $121.90, enjoying a lift after being maintained at a "buy" rating at Needham. The brokerage also hiked its price target on DDOG to $140 from $130. Should today's gains hold, the stock will snap a three-day losing streak and chip off some of its year-to-date deficit of 16%.

Datadog stock has struggled to maintain any significant gains in 2025, most recently facing off against its 120-day moving average and the $120 level. Shares remain almost 30% off their December multi-year peak.

Heading into today analysts are heavily bullish, with 31 of 39 in coverage sporting a "buy" or "strong buy" recommendation. Plus, the average 12-month price target of $138.61 comes in at a 14% premium to current levels.

Options look affordable, per Datadog stock's Schaeffer's Volatility Index (SVI) of 35%, which ranks in the 9th percentile of its annual range. This means options traders are pricing in low volatility expectations. DDOG has a tendency to outperform these expectations, per its Schaeffer's Volatility Scorecard (SVS) of 79 out of 100. 

 

Oracle Corp (NYSE:ORCL) stock is up 10.4% to trade at $194.64 at last check, after the cloud computing giant reported a fourth-quarter earnings and revenue beat. The company also issued an upbeat annual revenue forecast thanks to strong cloud artificial intelligence (AI) demand. At least 10 analysts hiked their price target in response, with the highest coming from Bernstein to $225 from $207.

The shares are set to resume gains after yesterday snapping a four-day win streak. Today's surge is also helping the security overcome resistance at the $180 region, which capped a February rally. Earlier jumping to its highest level of 2025, ORCL now sports a 42.4% year-over-year lead.

Drilling down to today's options activity, 76,000 calls and 40,000 puts have crossed the tape in just the first half hour of trading, which is 21 times the volume typically seen at this point. The most popular contract is the weekly 6/13 200-strike call, followed by the 195-strike call in that series, with new positions now opening at both.

Biotech stock Crispr Therapeutics Inc's (NASDAQ:CRSP) June rally appears to be coming to an end. The shares are looking to snap a seven-day win streak, down 0.6% at $42.69 at last glance. Plus, after hitting its highest level since March, the stock is now flashing a historically bearish signal on the charts. 

Per Schaeffer's Senior Quantitative Analyst Rocky White, CRSP has moved up toward its 260-day moving average. More specifically, the security is within 0.75 of the trendline's 20-day average true range (ATR) after spending at least 80% of the last 10 days and 80% of the last two months below it. 

Within these parameters, five other signals occurred in the past three years. CRSP was lower one month later 80% of the time after these events, averaging an 8% loss. From their current perch, a similar move would put the shares back below the $40 level, which acted as resistance from mid-April to late last week. 

Options bulls have been blasting Crispr Therapeutics stock over the last two weeks, and an unwinding of this optimism could provide further headwinds. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), 14.50 calls have been bought for every put in the last two weeks, which is a higher ratio than 99% of readings from the past year. 

Aerospace manufacturer Lockheed Martin Corp (NYSE:LMT) stock is gapping lower today, after a U.S. Defense Department procurement request sent to Congress asked for 24 of the company's F-35 jets for the U.S. Air Force, compared last year's forecast of 48. The halved order has traders eyeing defense sector peers Northrop Grumman Corp (NYSE:NOC) and RTX Corp (NYSE:RTX) as well. 

LMT was last down 5.4% to trade at $451.30, pacing for a third-straight daily drop as it dives below recent support from the 20-day moving average. A floor at the $440 level that contained bear gaps in April and May looks ready to cap today's losses, however. Year-to-date, the equity is down 6.5%.

NOC is down 1.2% to trade at $482.72 at last check, after yesterday failing to conquer a ceiling at $500 that also rejected a May rally. Shares are testing support at their own 20-day trendline, but sport a 12.3% lead for the last 12 months and remain on the positive side of their year-to-date breakeven point.

Unlike its peers, RTX was last seen up 1% to trade at $139.84, following a price-target hike at Jefferies to $155 from $130. The security is set to resume gains after yesterday snapping its eight-day win streak, though it still nabbed a record high of $141.12 last session before pivoting lower. RTX has added over 20% so far in 2025.

In the options pits, LMT is the only one seeing unusual activity. So far today, the stock has seen 13,000 calls and 6,763 puts cross the tape, which is already 2.5 times the overall options volume typically seen in an entire session. The most active contract by far is the July 520 call, followed by the January 2026 600-strike call.